Development and antimicrobial susceptibility studies of in vitro monomicrobial and polymicrobial biofilm models with Aspergillus fumigatus and Pseudomonas aeruginosa.
about
Effects of Propidium Monoazide (PMA) Treatment on Mycobiome and Bacteriome Analysis of Cystic Fibrosis Airways during ExacerbationHarnessing Bacterial Signals for Suppression of Biofilm Formation in the Nosocomial Fungal Pathogen Aspergillus fumigatusRedox metabolites signal polymicrobial biofilm development via the NapA oxidative stress cascade in Aspergillus.Inhibition of Aspergillus fumigatus and Its Biofilm by Pseudomonas aeruginosa Is Dependent on the Source, Phenotype and Growth Conditions of the Bacterium.Biofilm models of polymicrobial infection.Characteristics of Aspergillus fumigatus in Association with Stenotrophomonas maltophilia in an In Vitro Model of Mixed Biofilm.Analysis of the Aspergillus fumigatus Biofilm Extracellular Matrix by Solid-State Nuclear Magnetic Resonance Spectroscopy.Effect of acute predation with bacteriophage on intermicrobial aggression by Pseudomonas aeruginosaThe Ecological Role of Type Three Secretion Systems in the Interaction of Bacteria with Fungi in Soil and Related Habitats Is Diverse and Context-Dependent.Bacterial Adaptation during Chronic Respiratory Infections.Drug treatments for prosthetic joint infections in the era of multidrug resistance.Fungal biofilm composition and opportunities in drug discovery.Prevention of polymicrobial biofilms composed of Pseudomonas aeruginosa and pathogenic fungi by essential oils from selected Citrus species.Pseudomonas aeruginosa inhibits the growth of Scedosporium aurantiacum, an opportunistic fungal pathogen isolated from the lungs of cystic fibrosis patients.3,5-Dicaffeoylquinic Acid Disperses Aspergillus Fumigatus Biofilm and Enhances Fungicidal Efficacy of Voriconazole and Amphotericin B.Fungal Biofilms and Polymicrobial Diseases.Interaction between and in cystic fibrosis
P2860
Q28584597-D43907BD-9C1C-4406-9AAD-3323A9E6874FQ28818788-64F6C58C-6C36-41C3-B637-5CA3A51BC80FQ34860400-C6A53554-9E1C-4703-ABB1-2F968433A557Q35739749-69DDBFE5-F138-4CAB-A1D7-24E34A906EBDQ35848074-30C27217-F74F-43D4-9575-D340EE2655DBQ36199673-4E0FD74F-14F6-4169-8B3B-B92C51C6BA28Q36208870-D705D6F2-B548-40DF-805E-5FE910827B42Q36407469-F2032730-F230-408E-B57D-475AFA3D71F0Q37615104-8091FB92-3D4F-480C-885A-85EFACE5BFD5Q38367560-21C8F08E-E469-4F35-9A3D-972E2671C3F8Q38800556-1E6265C2-3196-44E9-82EF-5D94A1697D97Q38835071-3F4A25A1-B92E-410D-9555-5957613C6AE9Q40517333-A6EE2164-D250-4655-A5F8-BA4BF484094DQ41949335-7869578E-B2D6-4437-B9A8-2FEAA48E3CE0Q49645904-1E2E8925-2CAB-495F-9060-562377B31FCFQ49679766-14119535-9F22-4F38-9140-B23CD1BE4382Q59137961-3DC53078-D29F-4CD0-8914-85C21BFE8759
P2860
Development and antimicrobial susceptibility studies of in vitro monomicrobial and polymicrobial biofilm models with Aspergillus fumigatus and Pseudomonas aeruginosa.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Development and antimicrobial ...... us and Pseudomonas aeruginosa.
@ast
Development and antimicrobial ...... us and Pseudomonas aeruginosa.
@en
type
label
Development and antimicrobial ...... us and Pseudomonas aeruginosa.
@ast
Development and antimicrobial ...... us and Pseudomonas aeruginosa.
@en
prefLabel
Development and antimicrobial ...... us and Pseudomonas aeruginosa.
@ast
Development and antimicrobial ...... us and Pseudomonas aeruginosa.
@en
P2093
P2860
P356
P1433
P1476
Development and antimicrobial ...... us and Pseudomonas aeruginosa.
@en
P2093
Dora L Vager
Elias K Manavathu
Jose A Vazquez
P2860
P2888
P356
10.1186/1471-2180-14-53
P577
2014-03-03T00:00:00Z
P5875
P6179
1036653257